Summary
The cell growth and monoclonal antibody production characteristics of two rat x mouse heterohybridoma cell lines, designated 187.1 and M1/9.3, were investigated using a biocompatible microencapsulation technology. Both cell lines, derived from the fusion of immunized rat spleen cells with either the NS1 or X63Ag8.653 myeloma cell lines, were found to reach a maximum intracapsular cell density of 1.3 to 1.5×107 cells/ml during a 27-d culture period. During this period, rat monoclonal antibody accumulated in the intracapsular space of both cultures to a final concentration of 2.0 to 2.8 mg/ml. Comparison of the concentration of rat monoclonal antibody in the extracapsular vs. the intracapsular space of both cultures indicated that significantly less than 1% of the antibody produced by the encapsulated hybridoma cells was capable of transiting the microcapsule membrane during the culture period. Due to the partition of the rat monoclonal antibody within the intracapsular space, the initial purity of the antibody harvested from 21-d microcapsule cultures of 187.1 and M1/9.3 cells was approximately 48 and 75% by weight, respectively. Analysis of the intracapsular protein by sodium dodecyl sulfoxide gel electrophoresis at different times during the culture period demonstrated that the principal contaminant associated with the unpurified antibody was bovine serum albumin.
Similar content being viewed by others
References
Arathoon, W. R.; Birch, J. R. Large-scale cell culture in biotechnology. Science 232:1390–1395; 1986.
Chapuis, B.; Helg, C.; Maurice, P., et al. Transplantation of allogeneic bone marrow treatedin vitro with Campath-1 monoclonal antibody. Schweiz. Med. Wochenschr. 115:1521–1522; 1985.
Davignon, D.; Martz, E.; Reynolds, T., et al. Lymphocyte function-associated antigen 1 (LFA-1): A surface antigen distict from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA 78:4535–4539; 1981.
Duff, R. G. Microencapsulation technology: a novel method for monoclonal antibody production. Trends Biotechnol. 3:167–170; 1985.
Feder, J.; Tolbert, W. R. Perfusion systems for plant scale mammalian cell culture production. Pharm. Engineering 5:23–49; 1985.
Jarvis, A. P.; Grdina, T. A. Production of biologicals from microencapsulated living cells. Bio Techniques 1:17–22; 1983.
Jarvis, A. P.; Grdina, T. A.; Sullivan, M. F. Growth and hemoglobin synthesis in murine erythroleukemic cells propagated in high density microcapsule culture. In Vitro 23:589–596; 1986.
Kirkman, R. L.; Barett, L. V.; Gaulton, G. N., et al. The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection. Transplantation 40:719–722; 1985.
Kohler, G.; Milstein, C. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256:495–497; 1975.
Labit, C.; Pierres, M. Rat monoclonal antibodies to mouse IgG1, IgG2a, IgG2b, and IgG3 subclasses and kappa chain isotypic determinants. Hybridoma 3:163–169; 1984.
Laemmli, U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680–683; 1974.
Lowry, O. H.; Rosebrough, N. J.; Farr, A. L., et al. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275; 1951.
Lydersen, B. K.; Pugh, G. G.; Paris, M. S., et al. Ceramic matrix for large-scale animal cell culture. BioTechnology 3:63–67; 1985.
Maloney, D. G.; Kaminski, M. S.; Burowski, D., et al. Monoclonal anti-idotype antibodies against the murine B cell lymphoma 38C13: Characterization and use of probes for the biology of the tumorin vivo andin vitro. Hybridoma 4:191–209; 1985.
Posillico, E. G. Microencapsulation technology for large-scale antibody production. Bio Technology 4:114–117; 1986.
Rupp, R. G. Use of cellular microencapsulation in large-scale production of monoclonal antibodies. In: Fader, J.; Tolbert, W., eds. Large-scale mammalian cell culture. New York: Academic Press; 1985; 19–38.
Salstrom, J. S.; Chadfield, R. C.; Murphy, T. J. Cellular Engineering: A new potential for molecular and cell biology. Bio Techniques 2:103–105; 1984.
Thierfelder, S.; Cobbold, S.; Kummer, U., et al. Anti-lymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added compliment. Exp. Hematol. 13:948–955; 1985.
Waldmann, H.; Polliak, A.; Hale, G., et al. Elimination of graftversus-host disease byin vitro depletion of lymphocytes with a monoclonal antibody (CAMPATH-1). Lancet 2:483–486; 1984.
Weber, K.; Osborne, M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244:4406–4412; 1971.
Weiss, S.; Lahmann, K.; Cohn, M. Monoclonal antibodies to murine immunoglobulin isotypes. Hybridoma 2:49–54; 1983.
Wofsy, D. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136:4554–4560; 1986.
Yelton, D. E.; Desaymard, C.; Scharf, M. D. Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma 1:5–11; 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilligan, K.J., Littefild, S. & Jarvis, A.P. Production of rat monoclonal antibody from rat x mouse hybridoma cell lines using microencapsulation technology. In Vitro Cell Dev Biol 24, 35–41 (1988). https://doi.org/10.1007/BF02623813
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02623813